Skip to main content
Advertisement
Live broadcast
Main slide
Beginning of the article
Озвучить текст
Select important
On
Off

Russian and Chinese developments in the field of controlled thermonuclear fusion have the potential for mutual enhancement and can become the basis for the implementation of joint projects, said Alexey Likhachev, CEO of Rosatom. At the same time, Russia and China are developing cooperation in the nuclear field in several areas at once, from the construction of nuclear power plants and fuel supplies to nuclear medicine. The partnership combines Russian technological expertise and Chinese manufacturing capabilities. The further development of cooperation between Moscow and Beijing depends on the decisions in the Izvestia article.

Key power units

Russia and China are developing a partnership in the nuclear industry in several areas at once, with the total investment in current joint projects estimated at about $6 billion. These include the construction of modern nuclear power plants with VVER—1200 reactors, the supply of a new generation of nuclear fuel, as well as joint developments in the field of fast neutron reactors and controlled thermonuclear fusion.

АЭС «Тяньвань»

Tianwan NPP

Photo: Global Look Press/Cfoto

Construction of power units No. 7 and No. 8 with Russian-made VVER-1200 reactors continues at the Tianwan NPP. After the commissioning of all eight units, the installed capacity of the station will be 9 GW. This will allow it to become the largest nuclear power plant in the world. At the same time, six of the eight power units were built using Russian technologies.

Power units No. 3 and No. 4 with VVER-1200 reactors are being built at the Xudapu NPP in Liaoning Province, near the city of Huludao. The launch of the first one is scheduled for the current year. In addition, Rosatom has begun supplying modern nuclear fuel to China for VVER-1200 reactors and fast neutron installations.

китай
Photo: Global Look Press/Cfoto

Russia is also helping China to develop the CFR-600 sodium reactor. Cooperation includes technological support and transfer of program codes.

Advanced medicine

Another area is nuclear medicine. Currently, Rosatom provides up to 80% of the Chinese market for a number of the most sought-after and scarce radioisotopes for radiopharmaceuticals. Russia supplies rare, high-tech and stable isotopes, which require unique reactors and centrifuge technologies. Among them are germanium-72, silicon-78 and helium-3.

Russian enterprises are able to produce isotopes in series and guarantee stable supplies, which is especially important against the background of the rapid growth of the nuclear medicine market in China. At the same time, cooperation continues to expand: at specialized exhibitions in China, the parties regularly sign new long-term agreements on the supply of scarce radioisotopes.

ампулы
Photo: IZVESTIA/Eduard Kornienko

Experts estimate that by 2030, the demand for nuclear medicine in China will increase by more than 10 times. However, even after the commissioning of new reactors, the country will not be able to fully supply itself with radioisotopes immediately. It is expected that China will cover the basic needs on its own, while Russia will maintain its position in the segment of the rarest and most technologically complex isotopes.

At the same time, the format of cooperation will change. China is increasingly developing local production and attracting international companies to produce ready-made radiopharmaceuticals. Under these conditions, Rosatom will have to gradually move from exporting isotope raw materials to creating high-tech products for nuclear medicine jointly with Chinese partners.

Gradual work

Russia and China are consistently expanding cooperation in the nuclear industry, the Rosatom press service confirmed to Izvestia. In 2023, the Russian state Corporation and the Atomic Energy Agency of the People's Republic of China signed a long-term program for fast neutron reactors and nuclear fuel cycle closure. In 2024, the parties approved a roadmap for its implementation, and in 2025, a memorandum on strategic cooperation in the field of peaceful atom. In May 2026, Rosatom CEO Alexey Likhachev signed three more memoranda with Chinese partners, which cover personnel training, thermonuclear fusion, nuclear medicine, and advanced scientific technologies.

Scientific cooperation remains one of the key areas. Russia and China are working together on the ITER project, conducting research in the field of controlled thermonuclear fusion and new materials for next-generation reactors. Chinese scientists also plan to use the MBIR research reactor for materials science tests, and Rosatom is already testing materials for Chinese generation IV salt melt reactors.

росатом
Photo: IZVESTIA/Sergey Konkov

Russia and China are expanding cooperation in the field of controlled thermonuclear fusion, a technology that could become a new source of virtually inexhaustible clean energy in the future. Russian specialists are participating in experiments at the Chinese tokamak EAST, where they are testing equipment for studying plasma, a super—hot substance necessary for a thermonuclear reaction. In addition, joint work has begun on the new BEST research reactor, and projects at the HL-3, HL-4 and CFETR facilities are also being discussed.

Positions in the Chinese market

Russia's position in the Chinese market of radioisotopes and nuclear materials remains quite stable, Vladislav Bukharsky, director of Sovereign and Regional Ratings at the Expert RA agency, told Izvestia. In 2025, the supply of Russian enriched uranium to China increased by 40%, and Russia's share in this market reached almost 95%.

"In the medium term, the balance may change if China implements its policy of diversifying suppliers and accelerating the development of its own technologies, although there are no real alternatives to Russia in terms of volume and range of supplies in the coming years," the expert believes.

топливо
Photo: IZVESTIA/Eduard Kornienko

At the same time, Russia and China have complementary competencies: the Russian side is strong in the design of nuclear reactors, closed fuel cycle technologies, materials science and the production of equipment for the nuclear industry. China's advantages are extremely strong production facilities, rapid introduction of new technologies into industry, and significant investments in research and development.

Strengthening Russian-Chinese cooperation can seriously affect the balance of power in the global nuclear industry, Pavel Sevostyanov, associate professor of the Department of Political Analysis and Socio-Psychological Processes at Plekhanov Russian University of Economics, told Izvestia. According to Rosatom, the company's foreign order portfolio exceeds $200 billion, and dozens of power unit construction projects are being implemented in different countries at the same time. At the same time, more than 60 power units are in operation in China, and several dozen more are under construction and preparation. Beijing ranks first in the world in terms of the pace of new capacity commissioning.

However, sanctions and export control restrictions remain a risk factor. They make it difficult to access certain types of equipment, specialized software, and high-tech components. As a result, international projects may face increased deadlines and increased costs.

Переведено сервисом «Яндекс Переводчик»

Live broadcast